Tweet
Guardian Liberty Voice
<img alt="" height="1" width="1" />
US FDA advisers back MannKind's inhaled diabetes drug
Reuters
HYATTSVILLE, Maryland (Reuters) - U.S. health advisers on Tuesday recommended approval of MannKind Corp's inhaled diabetes drug, and said the experimental treatment could help some patients, especially those wary of needles typically used with ...
FDA Panel Says Yes to Inhaled Insulin DeviceMedPage Today
MannKind Says FDA Advisory Committee Recommends Approval of Afrezza ...Wall Street Journal
MannKind Wins US Panel Backing for Inhaled Insulin AfrezzaBusinessweek
New York Times -MarketWatch
all 58 news articles »
More...